01-02-2018 | Correction
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2018
Login to get access